Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.51 |
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | AGXT | P21549 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.49 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.48 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.48 |
| ▸ | TSPO | P30536 | 1/20 | 0.47 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30855352 | 1.00 | TAAR1 (0.51) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL29194742 | 0.95 | CALM1 (0.55) | TAAR1IDO1AGXTPOLBCALM1 | |
| SCHEMBL30245845 | 0.90 | POLB (0.46) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL29194663 | 0.90 | POLB (0.46) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL25291376 | 0.89 | SLC2A1 (0.44) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL30246188 | 0.89 | SLC2A1 (0.44) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL29194714 | 0.86 | POLB (0.59) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL30245952 | 0.86 | POLB (0.59) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL28267855 | 0.86 | AOC3 (0.53) | TAAR1IDO1AGXTPOLBAOC3 | |
| SCHEMBL30246316 | 0.84 | HSD17B2 (0.56) | TAAR1IDO1AGXTAOC3HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1280495-A2 | 3-METHOXYBENZYL THIOUREA DERIVATIVES AND IMPROVED LIPID COMPOSITIONS CONTAINING SAME | Abbott, Thomas, P. (US) | 2003-02-05 | — | — | EP | claimed |
| WO-2001085681-A2 | 3-METHOXYBENZYL THIOUREA DERIVATIVES AND IMPROVED LIPID COMPOSITIONS CONTAINING SAME | THE FANNING CORPORATION (US) | 2001-11-15 | — | — | WO | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | disclosed |
| EP-1155677-B1 | Compositions for inhibiting free radical polymerization in skin and hair | FAN TECH LTD (US) | 2007-06-13 | — | — | EP | disclosed |
| US-20030114532-A1 | Methods and compositions for inhibiting free radical polymerization in skin and hair | FAN TECH, LTD. | 2003-06-19 | — | — | US | disclosed |
| US-6545052-B2 | Contacting skin with skin treatment composition having concentration of 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation | FAN TECH, LTD. | 2003-04-08 | — | — | US | disclosed |
| US-20020094342-A1 | Methods and compositions for inhibiting free radical polymerization in skin and hair | FAN TECH, LTD. | 2002-07-18 | — | — | US | disclosed |
| EP-1155677-A2 | Methods and compositions for inhibiting free radical polymerization in skin and hair | Fan Tech Ltd. (US) | 2001-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094342-A1 | Methods and compositions for inhibiting free radical polymerization in skin and hair | TST, BHMT2, TXN2 | TAAR1 4418/4885IDO1 660/4885AGXT 718/4885 |
| US-20030114532-A1 | Methods and compositions for inhibiting free radical polymerization in skin and hair | TST, BHMT2, TXN2 | TAAR1 4418/4885IDO1 660/4885AGXT 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.